CLINICAL_TRIALS
research
· 2026-04-03
Clinical Trial Update: Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp [Phase 3]
Summary
A Phase 3 study to evaluate the safety, tolerability, and efficacy of Ameluz (BF-200 ALA) for field-directed photodynamic therapy of actinic keratosis on the ex…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biofrontera Inc. | Conditions: Actinic Keratoses | Phase 3 | Status: ACTIVE_NOT_RECRUITING